This study was presented as part of the session “Diabetes and Heart Talk” on June 23rd, 2025, during the 85th ADA Scientific Sessions held in
This study was presented on June 23rd, 2025, during the 85th ADA Scientific Sessions held in Chicago, IL. A groundbreaking obesity treatment combining two medications
This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity” on June 22nd, 2025, at
This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at the 85th ADA Scientific Sessions
This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity” on June 22nd, 2025, at
This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at the 85th ADA Scientific Sessions
This paper was presented as a part of the session “Dropping Cost and Complications—CVD Risk and DM—SGLT2s and GLPs for CVD” on June 22nd, 2025,
This paper was presented as a part of the session “The Tidal Wave Is Coming—Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2
This paper was presented as a part of the session “The Tidal Wave Is Coming—Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2
This session was presented on June 21st, 2025, at the 85th ADA Scientific Sessions being held in Chicago, IL. A major international clinical trial has